ETOPOPHOS
NDC 61269-410, etoposide phosphate, injection, powder, lyophilized, for solution, from H2-Pharma, LLC.
- Product NDC
- 61269-410
- Status
- Listed
- Labeler
- H2-Pharma, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020457
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61269-410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETOPOSIDE PHOSPHATE100 mg/1
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61269-410-20 | 61269041020 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61269-410-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7499fc35-fae8-44ad-bbab-9a1a589bf3eeMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61269-410
Use it
Look up 61269-410 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61269-410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61269-410. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.